Overview
The single most popular peptide in the wellness market, and the widest gap on this site between reputation and evidence. Hundreds of rodent studies show impressive healing effects. Published randomized human trials showing the same: none.
Not approved for human use anywhereNo approval anywhere for human use. Sold under research-use labelling. Not an approved drug. Not a lawful dietary supplement. Not eligible for pharmacy compounding in the US. Sold under "research use only" labelling that does not confer legality for human use.
| Regulatory status | Not approved. FDA placed BPC-157 in Category 2 of its bulk-substance review in 2023, barring it from lawful compounding. WADA-prohibited since 2022. |
|---|---|
| Drug class | Synthetic pentadecapeptide derived from a sequence in human gastric juice protein BPC |
| Route | Oral or subcutaneous (research) |
| Half-life | Not established in humans |
| Evidence rating |
1/5 Minimal
Evidence rating 1 out of 5: Minimal
Animal or laboratory data only. No human efficacy evidence. |
| Studied in | Extensive rodent models of tendon, ligament, muscle, bone, gut and nerve injury, largely from a small number of affiliated research groups. Early human safety work exists for an oral formulation in inflammatory bowel disease; efficacy results were never published in the peer-reviewed literature. |
How it works
Proposed to upregulate VEGFR2 signalling and angiogenesis, modulate nitric oxide pathways, increase fibroblast migration and tendon-derived cell outgrowth, and interact with the gut-brain axis. Mechanistic work is almost entirely rodent and in-vitro.
Evidence base
Rated 1 of 5 — Minimal. Animal or laboratory data only. No human efficacy evidence.
- Rodent evidence base is unusually large for a research peptide — but preclinical promise routinely fails to replicate in humans.
- The absence of human trials after two decades of interest is itself informative.
Benefits & potential uses
Bars indicate how well each claim is supported: three = strong human evidence, two = moderate, one = preliminary or preclinical.
-
Consistent tendon and ligament healing in rodents Preliminary
Multiple animal models show accelerated tendon-to-bone healing and improved biomechanical strength. The animal literature is genuinely large and internally consistent.
-
Gut protection in animal models Preliminary
Protects against NSAID-induced and other experimental gut injury in rodents, which is where the compound originated.
-
Angiogenic activity Preliminary
Promotes new blood-vessel formation in preclinical models — the likely common mechanism behind the varied healing effects.
-
Low acute toxicity in animals Preliminary
Rodent toxicology has not identified a clear toxic dose, though this says little about chronic human exposure.
Risks, cons & cautions
Bars indicate seriousness: three = serious or common, two = moderate, one = minor.
-
No published randomized human trials Serious
Every efficacy claim made for BPC-157 in humans is extrapolated from rodents or drawn from anecdote. This is the central fact about it.
-
Angiogenesis cuts both ways Serious
The same new-blood-vessel formation that helps a tendon heal is a mechanism tumours depend on. There is no data on use in people with occult or prior malignancy.
-
Banned from compounding by FDA Serious
FDA concluded there was insufficient safety information to permit compounding — a formal regulatory judgement, not an oversight.
-
Product quality is frequently poor Serious
Independent testing of grey-market peptide vials has repeatedly found incorrect content, degradation products, and bacterial contamination.
-
Unknown long-term effects Serious
No chronic exposure data at all. Users are the study population.
-
Prohibited in sport Moderate evidence
Added to the WADA prohibited list in 2022; athletes have been sanctioned.
Who should avoid it
- Anyone with a cancer history or undiagnosed mass
- Pregnancy and breastfeeding
- Tested athletes
- Anyone who cannot verify product identity and sterility
If used under medical supervision, monitor
- No validated monitoring exists; discuss any use with your physician
Commonly confused with
These mix-ups cause real harm — two products sold under one name, or two molecules whose effects run in opposite directions.
PDA is the same pentadecapeptide as an arginate salt, marketed as a compliant alternative after FDA barred BPC-157 from compounding. Renaming a substance does not make it approved, and PDA has no independent studies of its own.
Compare side by sideRoutinely sold and used together for injury recovery. Neither has published randomized human trials for musculoskeletal healing, and both are WADA-prohibited.
Compare side by sideRegulatory & legal status
Not an approved drug. Not a lawful dietary supplement. Not eligible for pharmacy compounding in the US. Sold under "research use only" labelling that does not confer legality for human use.
Infographic
Where to read further
We link to live literature searches rather than a frozen citation list, so you always see current results — including anything published after our last review.
- PubMed — all published literature on BPC-157
- PubMed — randomized controlled trials only
- ClinicalTrials.gov — registered human trials
Related peptides in Healing & Tissue Repair
Terms used on this page
- Angiogenesis
- Angiogenesis is the sprouting of new capillaries from existing vessels, the process that supplies oxygen and nutrients to a healing wound or a growing tumour alike.
- Nitric Oxide
- Nitric oxide is a short-lived gaseous signalling molecule made from arginine by nitric oxide synthase that relaxes vascular smooth muscle and participates in immunity and repair.
- Fibroblast
- A fibroblast is the mesenchymal cell that produces and maintains connective tissue matrix, and which differentiates into a contractile myofibroblast during wound repair.
- Preclinical Study and Animal Model
- Preclinical studies are the laboratory, cell and animal experiments done before any human exposure, establishing mechanism, target engagement and the toxicology package that permits a first trial.
- Testimonial and Anecdote as Evidence
- Testimonial and anecdotal evidence is an uncontrolled personal report of an outcome, useful for generating hypotheses and flagging rare harms but unable to establish that a treatment worked.
- Tendon Structure
- Tendon is a hierarchical collagen composite transmitting muscle force to bone, built from fibrils and fascicles held in a sliding matrix and populated sparsely by tenocytes.
This page is educational information, not medical advice. It cannot account for your medical history, medications, or risk factors. Do not start, stop or change any treatment based on it. Speak to a qualified healthcare professional who knows your case.